| Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative SK Malladi, UR Patel, RS Rajmani, R Singh, S Pandey, S Kumar, ... ACS Infectious Diseases 7 (8), 2546-2564, 2021 | 33 | 2021 |
| Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity S Kumar, R Delipan, D Chakraborty, K Kanjo, R Singh, N Singh, ... Journal of Virology 97 (11), e00922-23, 2023 | 6 | 2023 |
| Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and … N Kumar, IM Taily, C Singh, S Kumar, RS Rajmani, D Chakraborty, ... PLoS pathogens 19 (5), e1011358, 2023 | 2 | 2023 |
| A highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative elicits high titers of neutralizing antibodies SK Malladi, UR Patel, RS Rajmani, R Singh, S Pandey, S Kumar, ... | 1 | 2021 |
| Enhanced protective efficacy of a thermostable RBD-S2 vaccine formulation against SARS-CoV-2 and its variants N Mittal, S Kumar, RS Rajmani, R Singh, C Lemoine, V Jakob, S Bj, ... npj Vaccines 8 (1), 161, 2023 | | 2023 |
| Enhanced protective efficacy of a novel, thermostable, RBD-S2 fusion immunogen against SARS-CoV-2 and its variants (preprint) N Mittal, S Kumar, RS Rajmani, R Singh, C Lemoine, V Jakob, ... | | 2023 |
| Diphenylurea derivatives broadly inhibit SARS-CoV-2 and influenza A virus infections by perturbing endocytic trafficking N Kumar, I Taily, C Singh, S Kumar, RS Rajmani, D Chakraborty, ... | | 2022 |
